Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ndovu9
    Junior Member
    • Jul 2013
    • 3

    #1

    RNASeq TPM vs. FPKM - What's the point if differential expression tools use counts?

    I am confused about RNASeq quantification and normalization. There seems to be debate on the correct way to normalize RNASeq data, and the creator of RPKM/FPKM now advocates using TPM instead (http://liorpachter.wordpress.com/201...t/#comment-246). However, Cuffdiff seems to be the only differential expression tool that uses normalized expression values (I may be wrong here), but it is not clear to me exactly how Cuffdiff works. In contrast, count based differential expression methods (DESeq, edgeR, EBSeq and others) try to use counts and do not focus of TPM vs. FPKM issues of normalization.

    My question is, what is the point of RNASeq normalization if the majority of differential expression methods do not even use these normalization methods? Is the normalization for comparison of the general "expression level" of a single gene across multiple samples, or possibly to understand whether a gene is highly or lowly expressed relative to other genes within a sample? Alternatively, should differential expression tools attempt to use normalized values?
  • samanta
    Senior Member
    • Feb 2010
    • 108

    #2
    Our blog has some discussion going on between Lior Pachter and Istvan that you may find helpful.

    http://homolog.us

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    38 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    44 views
    0 reactions
    Last Post SEQadmin2  
    Working...